You have noted that 70 mg/dL is the “AHA Guideline” threshold for the LDL-C level in high-risk patients, but when in your view is more aggressive lowering to levels such as those observed in the ODYSSEY Outcomes and FOURIER trials justified?

You have noted that 70 mg/dL is the “AHA Guideline” threshold for the LDL-C level in high-risk patients, but when in your view is more aggressive lowering to levels such as those observed in the ODYSSEY Outcomes and FOURIER trials justified?

You have noted that 70 mg/dL is the “AHA Guideline” threshold for the LDL-C level in high-risk patients, but when in your view is more aggressive lowering to levels such as those observed in the ODYSSEY Outcomes and FOURIER trials justified?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical Cardiology, Interventional Cardiology, Lipid Medicine, Atherosclerosis and Diabetes Specialist's Perspective

Presenter

Christian Ruff, MD

Christian Ruff, MD

Christian Ruff, MD Principal Investigator, ENGAGE-AF Trial TIMI Group Director, General Cardiology Brigham and Women’s Hospital Assistant Professor of Medicine Harvard Medical School Boston, MA